Status Covid-19/Flu A/B

$536.23 $428.99

Sample Type: nasopharyngeal swab specimens
Detection Method: Colloidal Gold
Detection Time: 15 minutes
COVID-19 – Anterior Nasal – Sensitivity 93.8%, Specificity 100%
Nasopharyngeal – Sensitivity 93.1%, Specificity 100%
• Flu A – Sensitivity 91.4%, Specificity 95.7%
• Flu B – Sensitivity 87.6%, Specificity 95.9%
Interim order: IO#326827
All necessary reagents provided and no equipment is needed

Status™ COVID-19/Flu A&B test is a lateral flow immunoassay intended for the in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS-CoV-2, influenza A and/or influenza B directly from nasopharyngeal swab specimens obtained from individuals, who are suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider, within the first five days of onset of symptoms.

Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high, or waived complexity tests. This product is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.



Package Size

1 Kit, 12 Kits, 50 Kits, 100 Kits


There are no reviews yet.

Be the first to review “Status Covid-19/Flu A/B”

Your email address will not be published. Required fields are marked *

Status Covid-19/Flu A/B
$536.23 $428.99Select options